Hematology and Oncology
Home Hematology and Oncology
Communication Program Doesn’t Raise Hospital Liability Costs
The few program events that met eligibility criteria for compensation were not costly to resolve
Overall Breast Cancer Incidence Up for Some in 2005-2014
Incidence up for Asian/Pacific Islanders, non-Hispanic blacks, Hispanics, not non-Hispanic whites
Legal Cannabis Use Common Among Cancer Patients
Legalization increases likelihood of use; most want information about the drug from their doctors
Hypermutated ctDNA Linked to Checkpoint Inhibitor Response
Patients with high alteration number in variants of unknown significance had better outcomes
Opioid Manufacturers to Provide Doctor Training
74 manufacturers of immediate-release opioids notified that drugs will be subject to requirements
September 2017 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for September 2017. This roundup includes...
Accurate Lung Cancer Staging Depends on Quality Nodal Exam
Difference in exam thoroughness may account for large regional differences in survival
Checkpoint Inhibitors No Less Safe With Radiation
Combination does not increase immune-related adverse events in metastatic lung cancer patients
Upper Abdominal Cancer Resections Up in Octogenarians
Increase in resection rates driven by trends in hepatic and pancreatic resections
Embezzlement Widespread in Medical Practices
Red flags include employee being secretive about their work, working late, not wanting to share tasks
